These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3327648)

  • 1. Oral micronized progesterone. Bioavailability pharmacokinetics, pharmacological and therapeutic implications--a review.
    Sitruk-Ware R; Bricaire C; De Lignieres B; Yaneva H; Mauvais-Jarvis P
    Contraception; 1987 Oct; 36(4):373-402. PubMed ID: 3327648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronized progesterone: vaginal and oral uses.
    Simon JA
    Clin Obstet Gynecol; 1995 Dec; 38(4):902-14. PubMed ID: 8616985
    [No Abstract]   [Full Text] [Related]  

  • 3. Micronized progesterone: clinical indications and comparison with current treatments.
    Fitzpatrick LA; Good A
    Fertil Steril; 1999 Sep; 72(3):389-97. PubMed ID: 10519605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.
    Muhn P; Krattenmacher R; Beier S; Elger W; Schillinger E
    Contraception; 1995 Feb; 51(2):99-110. PubMed ID: 7750297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
    Muhn P; Fuhrmann U; Fritzemeier KH; Krattenmacher R; Schillinger E
    Ann N Y Acad Sci; 1995 Jun; 761():311-35. PubMed ID: 7625729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of micronized progesterone on the endometrium: a systematic review.
    Stute P; Neulen J; Wildt L
    Climacteric; 2016 Aug; 19(4):316-28. PubMed ID: 27277331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M
    JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of micronized natural progesterone in late human pregnancy. Effects on progesterone and estrogen concentrations in the plasma, placenta, and myometrium.
    Ferre F; Uzan M; Janssens Y; Tanguy G; Jolivet A; Breuiller M; Sureau C; Cedard L
    Am J Obstet Gynecol; 1984 Jan; 148(1):26-34. PubMed ID: 6691378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral micronized progesterone.
    de Lignières B
    Clin Ther; 1999 Jan; 21(1):41-60; discussion 1-2. PubMed ID: 10090424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of micronized progesterone: a review and more experience.
    McAuley JW; Kroboth FJ; Kroboth PD
    Pharmacotherapy; 1996; 16(3):453-7. PubMed ID: 8726605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability of orally and vaginally administered progesterone.
    Norman TR; Morse CA; Dennerstein L
    Fertil Steril; 1991 Dec; 56(6):1034-9. PubMed ID: 1743318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone.
    Simon JA; Robinson DE; Andrews MC; Hildebrand JR; Rocci ML; Blake RE; Hodgen GD
    Fertil Steril; 1993 Jul; 60(1):26-33. PubMed ID: 8513955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The endometrium under the effects of hormone replacement therapy in menopause with percutaneous estradiol and low-dose micronized progesterone].
    Philippe E; Faguer B; Engelman A; Charpin C; Loubière R; de Mascarel A; Leduc F; Dupin P; Hemet J; Vauzelle JL
    Pathologica; 1993; 85(1099):475-87. PubMed ID: 8127629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progesterone, progestagens in premenstrual syndrome, the perimenopause and the menopause].
    Salvat J; Jolles C
    Praxis (Bern 1994); 1995 Jan; 84(3):70-5. PubMed ID: 7846431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micronized progesterone: a new option for women's health care.
    Wetzel W
    Nurse Pract; 1999 May; 24(5):62-6, 71, 75-6. PubMed ID: 10349670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of micronized progesterone on breast cancer risk: a systematic review.
    Stute P; Wildt L; Neulen J
    Climacteric; 2018 Apr; 21(2):111-122. PubMed ID: 29384406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of oral administration of progesterone for premature labor.
    Erny R; Pigne A; Prouvost C; Gamerre M; Malet C; Serment H; Barrat J
    Am J Obstet Gynecol; 1986 Mar; 154(3):525-9. PubMed ID: 3513581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone.
    Shulman LP
    J Womens Health (Larchmt); 2006 Jun; 15(5):584-90. PubMed ID: 16796485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seminal plasma hormone concentration after oral application of progesterone.
    Feuring M; Bertsch T; Tran BM; Rossol-Haseroth K; Losel R; Tillmann HC; Schultz A; Weigel M; Wehling M
    Int J Clin Pharmacol Ther; 2002 Feb; 40(2):47-52. PubMed ID: 11862972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.